Growth differentiation factor‐15, treatment with liraglutide, and clinical outcomes among patients with heart failure

Growth differentiation factor‐15, treatment with liraglutide, and clinical outcomes among patients with heart failure

Abstract Aims Associations between growth differentiation factor‐15 (GDF‐15), cardiovascular outcomes, and exercise capacity among patients with a recent hospitalization for heart failure (HHF) and heart failure with reduced ejection fraction (HFrEF) are unknown. We utilized data from the ‘Functiona...

Full description

Bibliographic Details
Main Authors: Abhinav Sharma, Stephen Greene, Muthiah Vaduganathan, Marat Fudim, Andrew P. Ambrosy, Jie‐Lena Sun, Steven E. McNulty, Adrian F. Hernandez, Barry A. Borlaug, Eric J. Velazquez, Robert J. Mentz, Adam D. DeVore, Brooke Alhanti, Kenneth Margulies, G. Michael Felker
Format: Article
Language:English
Published: Wiley 2021-08-01
Series:ESC Heart Failure
Subjects:
GDF‐15
Heart failure
Liraglutide
GLP‐1 receptor agonist
Online Access:https://doi.org/10.1002/ehf2.13348

Internet

https://doi.org/10.1002/ehf2.13348

Similar Items